Tuesday, July 07, 2009

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastase

Denosumab Significantly Delayed the Time to the First Skeletal Related Event and Significantly Reduced First and Subsequent Skeletal Related Events Compared to Zometa

First of Three Pivotal Oncology Trials Comparing Denosumab to Zometa in the Advanced Cancer Setting Meets Primary and Secondary Endpoints

THOUSAND OAKS, Calif. – July 7 – Amgen (Nasdaq: AMGN) today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa. Superiority was demonstrated for both delaying the time to the first on-study Skeletal Related Events (SREs)(fracture, radiation to bone, surgery to bone, or spinal cord compression) (hazard ratio 0.82, 95 percent CI: 0.71, 0.95), and delaying the time to the first-and-subsequent SREs (hazard ratio 0.77, 95 percent CI: 0.66, 0.89). Both results were statistically significant.

Read the rest of this entry

Posted in Press Releases

Monday, July 06, 2009

Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn

Eight Inspiring People Will Model Custom-Designed Outfits Created by Emerging Talent from the Fashion Institute of Technology

NEW YORK – July 6 – Amgen and Wyeth today announced the eight winners of the Addressing Psoriasis(TM) contest, which recognizes people with moderate to severe plaque psoriasis who have tried not to allow the condition to inhibit their personal style. The winners will help raise public awareness of the condition by walking the runway in the Addressing Psoriasis(TM) Fashion Show hosted by television host and fashion consultant, Tim Gunn ("Project Runway," and "Tim Gunn’s Guide to Style"), on Sept. 2, 2009.

Read the rest of this entry

Posted in Press Releases

Monday, July 06, 2009

Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn

Eight Inspiring People Will Model Custom-Designed Outfits Created by Emerging Talent from the Fashion Institute of Technology

NEW YORK – July 6 – Amgen and Wyeth today announced the eight winners of the Addressing Psoriasis(TM) contest, which recognizes people with moderate to severe plaque psoriasis who have tried not to allow the condition to inhibit their personal style. The winners will help raise public awareness of the condition by walking the runway in the Addressing Psoriasis(TM) Fashion Show hosted by television host and fashion consultant, Tim Gunn ("Project Runway," and "Tim Gunn’s Guide to Style"), on Sept. 2, 2009.

Read the rest of this entry

Posted in Press Releases

Wednesday, June 17, 2009

34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence

2009 Awardees Recognized in Amgen Communities Across North America

THOUSAND OAKS, Calif. – June 17, 2009 – Amgen (Nasdaq: AMGN) today announced the 34 science teachers in the United States (U.S.), Canada and Puerto Rico who are this year’s recipients of the Amgen Award for Science Teaching Excellence. The award recognizes teachers in grades K-12 whose dedication to students has had a significant impact on the learning and interest of the future generation of scientists.

Read the rest of this entry

Posted in Philanthropy, Press Releases

Wednesday, June 10, 2009

Statement in Response to FTC Report on Biosimilars

THOUSAND OAKS, Calif.–June 10, 2009–As a biotechnology pioneer committed to developing first-in-class medicines that treat serious illnesses and unmet health needs, Amgen believes that an abbreviated biosimilar approval pathway must not discourage the development of groundbreaking new treatments for serious diseases. 

Read the rest of this entry

Posted in Company Statements